Biological E gets DCGI nod for Phase 3 clinical trials of Corbevax as booster dose December 28, 2021 Get link Facebook X Pinterest Email Other Apps Biological E, Hyderabad-based pharmaceutical company on Tuesday received the emergency-use authorisation for manufacturing and marketing of Corbevax. from Latest News https://ift.tt/317l9lr Comments
Comments
Post a Comment